Related Experiment Video
Updated: Feb 24, 2026
11:46
Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
Published on: April 27, 2014
18.4K
Association Between Irritable Bowel Syndrome and Overactive Bladder: A Research Survey
Kyu Shik Kim1, Hyung-Jee Kim2, Seong Ho Lee3
1Department of Urology, Hanyang University College of Medicine, Seoul, Republic of Korea.
Urology
|August 15, 2017
Summary
This study found no direct relationship between irritable bowel syndrome (IBS) and overactive bladder (OAB) in adults. Further research is recommended to explore potential connections between these conditions.
Area of Science:
- Gastroenterology
- Urology
- Clinical Research
Background:
- Irritable Bowel Syndrome (IBS) and Overactive Bladder (OAB) are common functional disorders.
- The potential relationship between IBS and OAB requires further investigation.
Purpose of the Study:
- To examine the association between IBS and OAB in adult men and women.
- To assess the prevalence of IBS and OAB and their correlation with other symptoms.
Main Methods:
- A multicenter survey involving 609 adults (older than 20 years).
- Utilized the Korean version of Rome III criteria for IBS diagnosis.
- Employed Overactive Bladder Symptom Score (OABSS) for OAB screening, Self-Rating Depression Scale for depressive symptoms, and International Prostate Symptom Score and Quality of Life for lower urinary tract symptoms.
Main Results:
- Prevalence rates were 31.9% for IBS and 19.2% for OAB.
- Individuals with IBS reported higher scores on the Self-Rating Depression Scale (44.92 ± 13.71 vs 39.19 ± 10.39, P < .001).
- No significant relationship was found between IBS and OAB, with non-IBS patients showing higher OABSS scores in both men and women.
Conclusions:
- The study did not establish a relationship between IBS and OAB in the studied adult population.
- Additional research is necessary to clarify the complex interplay between IBS and OAB.
Related Concept Videos
01:17Irritable Bowel Syndrome I: Introduction
1.2K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.2K
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
981
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
981
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
927
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
927
01:17Drugs for Treatment of Diarrhea-Predominant IBS
783
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
783
01:17Chronic Bowel Disorders: Introduction
841
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
841
01:23Urinary Bladder
3.8K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
3.8K